Amendment 1 ( ): Extension of primary outcome measure (Acrophobia Questionnaire) by 6-month follow-up



Similar documents
Feasibility study to evaluate the usability of the newly developed health care management software ecare*seniors in primary care practices.

Evaluation of a patient's ressource srengthening psychotherapeutic intervention in treatment of residual depression symptoms

Raman spectroscopy: Setup of an experimental system for analysis of urinary stone composition

WAKE-Up Pilot Study, Mental Training for patients with relapse-remitting multiple sclerosis and fatigue

In this observational study, the effect of dabigatran and rivaroxaban on platelets will be evaluated.

Work-related diseases of occupational therapists - pilot study for creating an "occupational therapist-cohort" in Germany

Trial Description. Organizational Data. Secondary IDs

Trial Description. DRKS-ID: DRKS Date of Registration in DRKS: 2015/03/06 Date of Registration in Partner Registry: [---]*

Dopaminergic and cholinergic modulation of oculomotor control during saccades

Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.

Changes in liver volume as determined by MRI scans after two weeks of a low energy diet (t0: before start of the diet; t1: after two weeks of diet)

Trial Description. DRKS-ID: DRKS Date of Registration in DRKS: 2014/10/31 Date of Registration in Partner Registry: [---]* Title

Prospective multicenter study for functional evaluation of transoral laser microsurgery (TLM) for supraglottic carcinomas - SUPRATOL

PLEASE NOTE: This study has been imported from ClinicalTrials.gov without additional data checks.

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Retrospective case record audit: service users who ended therapy

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol

NSW Cancer Trials Network Network Portfolio Policy October 2012

Submission Date: Project Start Date: Approximate Project End Date:

2C: Community Rehabilitation and Treatment Programs

Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics

ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW

If several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form.

Staying connected: Personality Disorder. Rachel C. Bailey & Brin F. S. Grenyer

SPECIALIST ARTICLE A BRIEF GUIDE TO PSYCHOLOGICAL THERAPIES

MSc Applied Child Psychology

Example CPD Submission

PARTICIPANT INFORMATION. The Oxford Access for Students Improving Sleep (OASIS) Study

Depression in Adults

Effect of liraglutide on body weight in overweight or obese subjects with type 2 diabetes: SCALE - Diabetes

PACKET OVERVIEW TABLE OF CONTENTS


Biostat Methods STAT 5820/6910 Handout #6: Intro. to Clinical Trials (Matthews text)

Austen Riggs Center Patient Demographics

Jayson Lee Mystkowski, Ph.D. 435 N. Bedford Dr., Suite 407 Beverly Hills, CA (310) (vm); (310) (f)

Programme Study Plan

Health Indicators. Issue 2-September 2011

Cognitive behavioral therapy (CBT) may improve the home behavior of children with Attention Deficit/Hyperactivity Disorder (ADHD).

PhD. IN (Psychological and Educational Counseling)

MADELYN GOULD, PhD, MPH

Rogers Memorial Hospital (Wisconsin).

Falling Between Two Stools. Dual Diagnosis: The need for multidisciplinary awareness and cooperation. Eoin Stephens

TREATING ASPD IN THE COMMUNITY: FURTHERING THE PD OFFENDER STRATEGY. Jessica Yakeley Portman Clinic Tavistock and Portman NHS Foundation Trust

Healthy Coping in Diabetes Self Management

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

DMRI Drug Misuse Research Initiative

Clinical Research at Harvard: Representative Scenarios

Networked Media Research Collaboration Programme

ADVANCED DIPLOMA IN COUNSELLING AND PSYCHOLOGY

A Phase II RCT of Stroke Navigators to Improve Compliance with Secondary Stroke Prevention: PROTECT DC

Definition of Terms. nn Mental Illness Facts and Statistics

Participating in Alzheimer s Disease Clinical Trials and Studies

RESEARCH SUBJECT INFORMATION AND CONSENT FORM

Clinical Trials: Questions and Answers

COURSE APPROVAL GUIDELINES APS COLLEGE OF SPORT PSYCHOLOGISTS

Hospitalization Risk Screening Tool for Primary Care Providers and Teams

M.A. DEGREE EXAMINATION, DECEMBER First Year. Psychology. Answer any FIVE of the following questions. Each question carries 15 marks.

APA Div. 16 Working Group Globalization of School Psychology

Sunderland Psychological Wellbeing Service

Personality Disorders (PD) Summary (print version)

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

Functional Specifications of the eztrial Clinical Trial Information Management System

Mental Health ICD-10 Codes Department of Health and Mental Hygiene

CRITICALLY APPRAISED PAPER (CAP)

What are Cognitive and/or Behavioural Psychotherapies?

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

A Phase 2 Study of Interferon Beta-1a (Avonex ) in Ulcerative Colitis

South Wilts Grammar School. When do teenage problems become Problems? A presentation by Dr. Anna Randle, Chartered Clinical Psychologist

IRB Committee Meeting Wednesday, September 15, 2010 Outside General Meetings Activity Update

REFERRAL INFORMATION CHILD, YOUTH AND FAMILY PROGRAM

Clinical Audit: Prescribing antipsychotic medication for people with dementia

Office ID Location: City State Date / / PRIMARY CARE SURVEY

Stage A & C Sample Data Collection Form

Clinical Trials. Helpful information and answers for patients

IAPT Data Set. Summary of validations undertaken upon receipt of data set by Bureau Service Portal. Version 1.2

REF/2011/03/ CTRI Website URL -

College of Education. Rehabilitation Counseling

STANDARD OPERATING POLICY AND PROCEDURE

R&D Administration Manager. Research and Development. Research and Development

Prepared by:jane Healey ( 4 th year undergraduate occupational therapy student, University of Western Sydney

LEBANESE MINISTRY OF HEALTH DIRECTIVE

Canines and Childhood Cancer

Template for essential information to be provided for proposals including clinical trials / studies / investigations

RESEARCH OBJECTIVE/QUESTION

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

Part II: Acceptance-Based Behavior Therapy for Depression and Social Anxiety

Clinical Study Synopsis

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Understanding Clinical Trials

Abnormal Psychology PSY-350-TE

SYNOPSIS. Risperidone: Clinical Study Report CR003274

chapter 1 Chapter 2 chapter 3

Basic Results Database

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

CPD sample profile. 1.1 Full name: Counselling Psychologist early career 1.2 Profession: Counselling Psychologist 1.3 Registration number: PYLxxxxx

A COMPARISON OF TWO TECHNIQUES TO REACH RELATIVES OF ALCOHOLICS FOR INFORMATION OF AVAILABLE SUPPORT

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Trauma Center Alcohol Screening. Michael Mello, MD, MPH Injury Prevention Center at Rhode Island Hospital /Hasbro Children s Hospital

What happens to depressed adolescents? A beyondblue funded 3 9 year follow up study

Transcription:

Trial Description Title Height anxiety study Trial Acronym [---]* URL of the trial [---]* Brief Summary in Lay Language The purpose of the study is to examine factors underlying exposure therapy in virtual reality. Exposure therapy is a form of cognitive behavioral therapy, where patients are confronted with their feared object or situation. Participants receive different instructions during exposure therapy. Participants are persons (18-65 years) with acrophobia. Amendment 1 (2016-06-01): Extension of primary outcome measure (Acrophobia Questionnaire) by 6-month follow-up Brief Summary in Scientific Language A therapy manual based on Emotional Processing Theory is compared with a manual based on inhibitory learning for exposure therapy for acrophobia. Participants are randomly assigned to one of two active groups and get two sessions of in-virtuo exposure therapy. Organizational Data DRKS-ID: DRKS00008999 Date of Registration in Partner Registry or other Primary Registry: [---]* Investigator Sponsored/Initiated Trial (IST/IIT): yes Ethics Approval/Approval of the Ethics Committee: Approved (leading) Ethics Committee Nr.: 19/14, Ethik-Kommission der Medizinischen Fakultät der Universität Würzburg Secondary IDs Page 1 of 5

Health condition or Problem studied ICD10: F40.2 - Specific (isolated) phobias Interventions/Observational Groups Arm 1: <style pdffontname='helvetica-bold' isbold='true'>virtual reality exposure therapy using an inhibitory learning approach [1]. Two sessions of individual therapy using a CAVE system within one week (ca. 45 min per session). [1] Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: an inhibitory learning approach. Behaviour Research and Therapy, 58, 10-23. </style> Arm 2: <style pdffontname='helvetica-bold' isbold='true'>virtual reality exposure therapy using an habituation based approach based on Emotional Processing Theory [1]. Two sessions of individual therapy using a CAVE system within one week (ca. 45 min per session). [1] Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: exposure to corrective information. Psychological Bulletin, 99(1), 20.</style> Characteristics Study Type: Interventional Study Type Non-Interventional: [---]* Allocation: Randomized controlled trial Blinding: [---]* Who is blinded: patient/subject Control: Active control (effective treament of control group) Purpose: Treatment Assignment: Parallel Phase: N/A Off-label use (Zulassungsüberschreitende Anwendung eines Arzneimittels): N/A Primary Outcome Acrophobia Questionnaire, at the beginning and the end of the study (2-3 days after the last exposure session), as well as a 6-month follow-up. Secondary Outcome Page 2 of 5

Behavioral Avoidance Test (subjective fear ratings while climbing the staircase of a parking lot), at the beginning and the end of the study (2-3 days after the last exposure session). Countries of recruitment DE Locations of Recruitment other Universität Würzburg, Würzburg Recruitment Planned/Actual: Actual (Anticipated or Actual) Date of First Enrollment: 2015/09/09 Target Sample Size: 50 Monocenter/Multicenter trial: Monocenter trial National/International: National Inclusion Criteria Gender: Both, male and female Minimum Age: 18 Years Maximum Age: 65 Years Additional Inclusion Criteria Acrophobia; diagnosed specific phobia using the SCID-I Exclusion criteria * Schizophrenia and other psychotic disorders * Major depression * Substance dependence * Cardiovascular disease * Pregnancy * Nausea in 3D movies < 3 (on a 0-10 scale) Addresses Primary Sponsor Page 3 of 5

Primary Sponsor E-mail: [---]* URL: [---]* Contact for Scientific Queries Mr. Daniel Gromer 97079 Würzburg Telephone: 09313180030 E-mail: daniel.gromer at uni-wuerzburg.de URL: http://www.i1.psychologie.uni-wuerzburg.de/ Contact for Public Queries Mr. Daniel Gromer Telephone: 09313180030 E-mail: daniel.gromer at uni-wuerzburg.de URL: http://www.i1.psychologie.uni-wuerzburg.de/ Sources of Monetary or Material Support Institutional budget, no external funding (budget of sponsor/pi) Page 4 of 5

Institutional budget, no external funding (budget of sponsor/pi) E-mail: [---]* URL: [---]* Status Recruitment Status: Recruiting ongoing Study Closing (LPLV): [---]* Trial Publications, Results and other documents * This entry means the parameter is not applicable or has not been set. Page 5 of 5